PURA Update Following Annual RPT To Highlight Increasing ALKM Interest, Breaking Ground In Farmersville w/PAOG and USMJ Partn...
April 12 2021 - 12:55PM
InvestorsHub NewsWire
PURA Schedules Update To Follow Upcoming
Annual RPT Highlighting Increasing Interest In ALKM, Breaking
Ground In Farmersville, And PAOG and USMJ
Partnerships
Dallas, TX -- April 12, 2021 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today announced a management update scheduled April
20th, 2021 to follow the upcoming FY2021 Annual Report
coming later this week.
The update will highlight PURA’s
commitment to striking on an opportunity to increase its ownership
in Alkame Holdings, Inc. above its recently acquired %5
interest.
The PURA management update will provide
even more thorough details on the Farmersville groundbreaking
planned for this summer beginning construction on PURA’s new
facilities to advance its Hemp Branding
strategy.
The PURA management update will also
highlight the latest progress with PAOG Group, Inc. (USOTC:
PAOG) in regard to the continued work between the two companies
to develop a variety of cannabis centric applications through a
partnership that initiated when PAOG acquired PURA’s cannabis
cultivation business last
year.
The PURA and PAOG partnership includes a
pending distribution of PAOG stock to PURA shareholders. PURA
shareholders are intended to receive one share of PAOG for every
PURA share they hold. The intended distribution has been
submitted for review by FINRA. Once the review process is
complete, PURA and PAOG plan to promptly proceed with the intended
distribution.
PURA and PAOG are joined on the
Farmersville project by North American Cannabis Holdings, Inc.
(USOTC:
USMJ) and
ALKM. The update next week will include the latest on the
partnerships and the Hemp Branding
strategy.
For more
information on Puration, visit http://www.purationinc.com
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Disclaimer/Safe
Harbor: This news
release contains forward-looking statements within the meaning of
the Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that Alkame will achieve significant sales, the failure
to meet schedule or performance requirements of the Company's
contracts, the Company's liquidity position, the Company's ability
to obtain new contracts, the emergence of competitors with greater
financial resources and the impact of competitive pricing. In the
light of these uncertainties, the forward-looking events referred
to in this release might not occur. These statements have not been
evaluated by the Food and Drug Administration. These products are
not intended to diagnose, treat, cure, or prevent any
disease.
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Aug 2024 to Sep 2024
North American Cannabis (CE) (USOTC:USMJ)
Historical Stock Chart
From Sep 2023 to Sep 2024